Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 Inhibition

1 Feb 2025

Abstract excerpt

Precision medicine approaches to cancer treatment aim to exploit genomic alterations that are specific to individual patients to tailor therapeutic strategies. Yet, some targetable genes and pathways are essential for tumor cell viability even in the absence of direct genomic alterations. In underrepresented populations, the mutational landscape and determinants of response to existing therapies are poorly...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Genomics and Diagnostics
Share to CAR-T cell therapy research
Share to CRISPR and Genetic Engineering

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 39891928
DOI: 10.1158/0008-5472.can-24-0775

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Kinome-Focused CRISPR-Cas9 Screens in African Ancestry Patient-Derived Breast Cancer Organoids Identify Essential Kinases and Synergy of EGFR and FGFR1 InhibitionPMID 39891928Read ↗

Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identifies essential kinases and synergy of EGFR and FGFR1 inhibitionSemantic proximity Read ↗

Kinome focused CRISPR-Cas9 screens in African ancestry patient-derived breast cancer organoids identify essential kinases and synergy of EGFR and FGFR1 inhibitionSemantic proximity Read ↗

Patient‐Derived Organoid‐Based <scp>CRISPR</scp> Screens in Cancer Research: Applications, Advances, and ChallengesSemantic proximity Read ↗

Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicineSemantic proximity Read ↗

A functional genetic toolbox for human tissue-derived organoidsSemantic proximity Read ↗

A functional genetic toolbox for human tissue-derived organoidsSemantic proximity Read ↗

MAGeCK enables robust identification of essential genes from genome-scale CRISPR/Cas9 knockout screens.Semantic proximity Read ↗

CRISPR Screens Provide a Comprehensive Assessment of Cancer Vulnerabilities but Generate False-Positive Hits for Highly Amplified Genomic Regions.Semantic proximity Read ↗

Challenges and Opportunities in Defining the Essential Cancer KinomeSemantic proximity Read ↗

A living biobank of canine mammary tumor organoids as a comparative model for human breast cancerSemantic proximity Read ↗

A living biobank of canine mammary tumor organoids as a comparative model for human breast cancerSemantic proximity Read ↗

Applications of CRISPR Technology to Breast Cancer and Triple Negative Breast Cancer ResearchSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.